Sonic Healthcare shares lift after EBITDA guidance reaffirmed
Make us a preferred source
Make us a preferred source on Google
The news: Pathology and diagnostic imaging provider Sonic Healthcare has seen its shares lift in morning trade after it reiterated FY26 EBITDA guidance and lowered guidance for depreciation and interest expenses.
The numbers: At 11:45am AEDT, shares in Sonic Healthcare had lifted 3.9% to $22.33 but were still down 18.4% in the year to date.
Ahead of its annual general meeting, Sonic Healthcare reaffirmed its full-year constant currency EBITDA guidance range of between $1.87 billion and $1.95 billion, which would be a roughly 13% year on year increase. The company also posted 17% statutory revenue growth in the year to October 2025.
It also lowered FY26 depreciation guidance range to below the previous forecast and lowered interest expense guidance to the lower end of the previous 15-20% guidance range.
RBC Capital Markets analyst Craig Wong-Pan said he expects this “should lead to consensus NPAT upgrades of at least 2%” when considering the midpoint of EBITDA guidance and the fall in depreciation and interest expense guidance.
The context: In a speech at Sonic Healthcare’s annual general meeting, chair Mark Compton said that the company has “a clear strategy to create value for shareholders through growth in earnings and returns on invested capital, in a sustainable manner”.
